|
Persistent HPV Infection in Women at Risk for Cervix Cancer
|
5U01CA078527-21
|
$581,591
|
|
BURK, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The role of macroH2A variants in cancer and senescence
|
5R01CA155232-08
|
$382,013
|
|
GAMBLE, MATTHEW
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
|
5R01CA178394-05
|
$346,525
|
|
GAVATHIOTIS, EVRIPIDIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Stand and Move at Work: A Group-Randomized Trial
|
5R01CA198971-04
|
$582,484
|
|
BUMAN, MATTHEW
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Exploiting the immune response to detect pathogen-induced cancers
|
5R01CA199948-04
|
$492,377
|
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Charge sensitive optical detection for high-throughput study of small molecules
|
5R33CA202834-03
|
$378,392
|
|
TAO, NONGJIAN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Role of SLC13A3 in Renal Cell Carcinoma
|
5F31CA210612-03
|
$29,664
|
|
JORDAN, ANDRE
|
AUGUSTA UNIVERSITY
|
|
Role of heat shock transcription factor HSF1 in tumoroginesis
|
5R01CA062130-23
|
$556,510
|
|
MIVECHI, NAHID
|
AUGUSTA UNIVERSITY
|
|
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
|
3R01CA190776-04S1
|
$116,456
|
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
Tumor Suppressor Localization and Function at the Peroxisome
|
5R01CA143811-10
|
$356,625
|
|
WALKER, CHERYL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Development of microRNA Biomarkers For Noninvasive Detection of Colorectal Cancer
|
5R01CA184792-04
|
$347,517
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
|
5R01CA197359-04
|
$388,875
|
|
BERLIN, JACOB
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting microRNAs to eradicate leukemia stem cells
|
5R01CA205247-02
|
$450,769
|
|
KUO, YA-HUEI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Epigenetic damage in women living in LA food-desert zip codes
|
5R01CA220693-02
|
$700,834
|
|
SEEWALDT, VICTORIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A New Mechanism for Castration Resistant Prostate Cancer
|
5R01CA166894-06
|
$368,984
|
|
SUN, ZIJIE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Basic and Translational studies of Ras-mutant colorectal cancer
|
5R01CA178017-05
|
$359,556
|
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
|
5R01CA196703-04
|
$404,888
|
|
CHIARLE, ROBERTO
|
BOSTON CHILDREN'S HOSPITAL
|
|
Role of m6A mRNA methylation in Neuroblastoma
|
5R21CA219352-02
|
$191,227
|
|
GREGORY, RICHARD
|
BOSTON CHILDREN'S HOSPITAL
|
|
Development of novel selective Rac inhibitors for refractory leukemias
|
5R01CA202756-03
|
$560,804
|
|
WILLIAMS, DAVID
|
BOSTON CHILDREN'S HOSPITAL
|
|
An assessment of whether aspirin and/or vitamin D improves breast cancer outcomes in Black women and the modifying effect of genetic variants
|
5K01CA212056-02
|
$133,775
|
|
BETHEA, TRACI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Molecular Mechanisms Regulating the Alternative Lengthening of Telomeres Pathway
|
5R01CA201446-03
|
$377,438
|
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
PAX3 pathways in melanoma
|
5R01CA184001-05
|
$377,438
|
|
LANG, DEBORAH
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Fate and efficacy of targeted therapies for metastatic tumors
|
5R01CA201148-04
|
$388,180
|
|
SHAH, KHALID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health Study
|
5UM1CA186107-05
|
$2,867,003
|
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas
|
5R01CA219943-02
|
$507,552
|
|
BEROUKHIM, RAMEEN
|
BROAD INSTITUTE, INC.
|
|
Engineering Triggered Nanomechanical Therapeutics
|
5R01CA140759-05
|
$303,525
|
$91,058
|
PIERCE, NILES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
|
5R01CA217956-02
|
$688,403
|
|
BRADY-KALNAY, SUSANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Imaging Liver Cancer Proliferation
|
5R01CA204373-03
|
$378,195
|
|
LEE, ZHENGHONG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
The Role of FOXCI in Basal-like Breast Cancer
|
2R01CA151610-06
|
$415,527
|
|
CUI, XIAOJIANG
|
CEDARS-SINAI MEDICAL CENTER
|
|
The Role of Splice Quantitative Traits in Ovarian Cancer Pathogenesis
|
5R21CA220078-02
|
$181,178
|
|
LAWRENSON, KATE
|
CEDARS-SINAI MEDICAL CENTER
|
|
Protein-DNA Drug Carriers for Targeting Drug-Resistant Tumors
|
5R01CA129822-08
|
$374,063
|
|
MEDINA-KAUWE, LALI
|
CEDARS-SINAI MEDICAL CENTER
|
|
Cancer-Associated Fibroblasts Alter the Composition of B cells in Solid Malignancies
|
5R01CA208753-03
|
$400,313
|
|
ORSULIC, SANDRA
|
CEDARS-SINAI MEDICAL CENTER
|
|
A blood test to identify prostate cancer patients at risk for visceral metastasis
|
5R01CA218356-02
|
$601,750
|
|
POSADAS, EDWIN
|
CEDARS-SINAI MEDICAL CENTER
|
|
The Impact of Macrophage Polarization on the Efficacy of Radiation Therapy
|
5K08CA191139-04
|
$176,796
|
|
SHIAO, STEPHEN
|
CEDARS-SINAI MEDICAL CENTER
|
|
Pediatric Preclinical Testing Consortium
|
5U01CA199287-04
|
$357,000
|
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Dietary Carcinogens for Colorectal Cancer
|
1R01CA229080-01A1
|
$366,000
|
|
LI, YONG
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Mechanism and treatment of PTEN mutant prostate tumorigenesis
|
5R01CA137050-09
|
$398,400
|
|
TROTMAN, LLOYD
|
COLD SPRING HARBOR LABORATORY
|
|
Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma
|
5R33CA196470-03
|
$386,051
|
|
LIN, QIAO
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Regulation of p53 acetylation and deacetylation in tumorigenesis
|
5R01CA085533-15
|
$288,000
|
|
GU, WEI
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Role of autophagy in normal and transformed hematopoietic stem cells
|
5R01CA184014-05
|
$332,000
|
|
PASSEGUE, EMMANUELLE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A Prospective, Randomized Study to Compare Effects of Ulipristal Acetate with a Combined Oral Contraceptive on Breast Epithelial Cell Proliferation.
|
5R01CA200795-03
|
$406,451
|
|
WESTHOFF, CAROLYN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The epigenetic mechanisms of high-grade pediatric glioblastoma
|
5R01CA204297-02
|
$365,348
|
|
ZHANG, ZHIGUO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Dynamic mRNA m6A modification in oncogenic translation
|
1R21CA227917-01
|
$204,885
|
|
QIAN, SHU-BING
|
CORNELL UNIVERSITY
|
|
Novel Roles for Oncogenic SOX2 in Esophageal Squamous Cell Carcinoma
|
5R01CA187119-04
|
$384,872
|
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
|
5R01CA188446-05
|
$765,486
|
|
BERBECO, ROSS
|
DANA-FARBER CANCER INST
|
|
Inflammation, Physical Activity, and Colon Cancer Recurrence and Survival
|
5K99CA218603-02
|
$139,840
|
|
BROWN, JUSTIN
|
DANA-FARBER CANCER INST
|
|
Human Cancer Suppressor Functions of Protein Phosphatase 2A
|
5P01CA203655-02
|
$1,613,905
|
|
DECAPRIO, JAMES
|
DANA-FARBER CANCER INST
|
|
Epigenetic mechanisms of drug resistance in T-cell acute lymphoblastic leukemia
|
5K08CA191091-04
|
$177,120
|
|
KNOECHEL, BIRGIT
|
DANA-FARBER CANCER INST
|
|
Determining the mutational landscape of circulating multiple myeloma cells
|
5K08CA191026-04
|
$177,120
|
|
LOHR, JENS
|
DANA-FARBER CANCER INST
|
|
End-of-Life Care for Adolescents and Young Adults with Cancer: An Evaluation of Care and Development of Patient-Centered Quality Measures
|
1R01CA218651-01A1
|
$671,298
|
|
MACK, JENNIFER
|
DANA-FARBER CANCER INST
|
Total relevant funding to Autoimmune Diseases for this search: $9,318,773
|